Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cytotools says Indian regulatory authorities recommend approval of Dermapro

Oct 30 (Reuters) - Cytotools AG  T5OG.DE : 
    * Indian regulatory authorities recommend approval of 
Dermapro, data of the phase III clinical trial to be submitted 
in November 
 
Source text for Eikon:  ID:nEQ9t2H3la  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on bioXXmed AG

See all news